0001209191-16-147236.txt : 20161028
0001209191-16-147236.hdr.sgml : 20161028
20161028131252
ACCESSION NUMBER: 0001209191-16-147236
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161026
FILED AS OF DATE: 20161028
DATE AS OF CHANGE: 20161028
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 161957851
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-10-26
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2016-10-26
4
M
0
6500
36.30
A
274725
D
Common Stock
2016-10-26
4
S
0
2000
77.80
D
272725
D
Common Stock
2016-10-26
4
S
0
1700
78.92
D
271025
D
Common Stock
2016-10-26
4
S
0
1100
80.06
D
269925
D
Common Stock
2016-10-26
4
S
0
1600
80.74
D
268325
D
Common Stock
2016-10-26
4
S
0
100
81.85
D
268225
D
Common Stock
13286
I
401(k)
Common Stock
78200
I
Common Stock Held In Trust
Stock Option (Right to Buy)
36.30
2016-10-26
4
M
0
6500
0.00
D
2017-01-23
Common Stock
6500
73000
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $77.80 (range $77.31 to $78.25).
Open market sales reported on this line occurred at a weighted average price of $78.92 (range $78.33 to $79.23).
Open market sales reported on this line occurred at a weighted average price of $80.06 (range $79.43 to $80.41).
Open market sales reported on this line occurred at a weighted average price of $80.74 (range $80.45 to $81.19).
Fully vested.
Omar White, Attorney-In-Fact
2016-10-28